Benoit Barteau

Benoit Barteau is a board member at Meiogenix. Benoit has also served as a board observer at Step Pharma and business developer at In Cell Art.

Barteau began their career as a trainee engineer at TcLand Expression. Benoit then transitioned to business development at In Cell Art, where they were responsible for strategies to increase short and long term sales, uncovering new markets, and developing new products.

In 2014, Barteau left In Cell Art to join Bpifrance. Benoit then joined the board of Step Pharma as an observer in 2015. In 2016, they joined Meiogenix as a board member.

Benoit Barteau is a board member at IFA - Institut Français des Administrateurs, where they earned their certificate. Benoit also has a private equity course from France Invest and a master's degree in finance from IAE Paris - Sorbonne Business School. Barteau also holds a PhD in immunology and biotechnology from Nantes Université, and is an engineer in biology and biotechnology from Université de Technologie de Compiègne (UTC). Benoit is also certified by the Autorité des marchés financiers (AMF) in France.